Ⅲ型肝门部胆管癌联合肝中叶切除（附8例分析）

目的：探讨肝中叶切除在III型肝门部胆管癌治疗中的临床应用。方法：回顾分析2005年—2009年8例III型肝门部胆管癌行肝中叶切除患者的临床资料,其中IIIa型7例,IIIb型1例;均行肝中叶切除,其中3例联合尾状叶切除,2例行肝动脉切除。结果：全组8例患者无一例手术死亡,全组并发症发生率为62.5%,生存时间最长已超过3年。结论：肝门部胆管癌联合肝叶切除可以提高患者预后,但在不影响预后的前提下,确定合适的手术范围以降低手术病死率及术后并发症发生率仍需进一步研究。

The Study of Bismuth-Corlette Type III Hilar Cholangiocarcinoma Combined with Hepatic Medical Lobectomy:a Report of 8 Cases

Objective：To investigate the clinical value of hepatic medical lobectomy for Bismuth-Corlette type Ⅲ hilar cholangiocarcinoma.Methods： The total of 8 cases of Bismuth-Corlette Ⅲ combined with hepatic medical lobectomy from 2005 to 2009 were analysed retrospectively.7 cases were type Ⅲa,the other was type Ⅲb.3 cases were combined with caudate lobectomy,2 cases were combined with hepatic artery resection,no one was combined with portal vein resection or reconstruction.Results： There was no operative death in the group,the incidence of postoperative complications of the 8 cases was 62.5%,the longest survive time was over 3 years.Conclusions： Combined hepatolotectomy of hilar cholangiocarcinoma may improve the prognosis of the patients,but under the condition without reducing prognosis,the further study of finding proper operative extension to avoid operative death rate and reduce the incidence of postoperative complications.